Molecular–clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach
- 1 December 2001
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 34, 75-80
- https://doi.org/10.1016/s0169-5002(01)00368-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Molecular pathogenesis of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Use of a yeast assay to detect functional alterations inp53 in prostate cancer: Review and future directionsThe Prostate, 1999
- Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Journal of Clinical Oncology, 1998
- Molecular abnormalities in lung cancer.Journal of Clinical Oncology, 1998
- p53-independent apoptosis induced by paclitaxel through an indirect mechanismProceedings of the National Academy of Sciences, 1997
- An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 1997
- BAX enhances paclitaxel-induced apoptosis through a p53-independent pathwayProceedings of the National Academy of Sciences, 1996
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Correlation of Intrinsic Chemoresistance of Non-Small-Cell Lung Cancer Cell Lines With HER-2/neu Gene Expression but Not With ras Gene MutationsJNCI Journal of the National Cancer Institute, 1993